Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If PTSC owned half the license - the the 3.5% should come only from TPL...
Reply New Message
Prev Message Back To Forum Threaded View Next Message

This issue/question should be addressed to the BoD for the SHM for clarification.

The 3.5% in question could be the difference between a dividend or no dividend to PTSC shareholders.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply